Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia

NCT02589340 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT02589340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02589340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia
Lead sponsor
Oregon Health and Science University
Phase
Phase 1
Overall status
Terminated
Start date
January 31, 2016
Completion date
February 23, 2021
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dyskinesias, movement disorders, parkinson's disease